trending Market Intelligence /marketintelligence/en/news-insights/trending/fu0uaxjgdtd2vijgmuoncq2 content esgSubNav
In This List

AmpliPhi Biosciences plans $3M common stock offering

Blog

Funding Social and Affordable Housing: A Credit Perspective

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals


AmpliPhi Biosciences plans $3M common stock offering

San Diego-based AmpliPhi Biosciences Corp. agreed to sell 2,743,640 common shares at $1.10 per share in an offering to certain institutional investors.

The company, which develops therapies for infections, expects gross proceeds of about $3 million. AmpliPhi plans to use the net proceeds for general corporate purposes.

H.C. Wainwright & Co. is the exclusive placement agent for the offering, which is expected to close by March 22.